How Germany’s Reimbursement System Evaluates Evidence and Cost Why the G-BA Matters In Germany, reimbursement decisions begin and end with the Gemeinsamer Bundesausschuss (G-BA) — the Federal Joint Committee responsible …

The Promise and the Paradox The UK Government’s 10-Year Health Plan for England (2025–2035) presents itself as a blueprint for a modernised NHS—one that is digitally enabled, outcomes-measured, genomically informed, …

Beginning in 2026, PMCF stops being a compliance afterthought and becomes the single biggest determinant of CE-mark renewal.Notified Bodies (NBs) are raising scientific standards, CORE-MD has formalised acceptable methodologies, and …

2025 Guide to Digital Therapeutics Reimbursement (CPT®, HCPCS, AI, CMS/AMA) The document includes verified CPT® and HCPCS codes, AI Category III routes, real-world case studies, state and federal policy signals, …

Discover how the NHS Innovator Passport and MedTech Compass are reshaping the pathway for medical technologies, diagnostics, and digital health innovations in the UK. These new frameworks enable faster, evidence-based …

Inside the Evidence Framework Behind Anbefalede Sundhedsapps and the Danish Board for Health Apps Updated: 3 November 2025 Contents Why this milestone matters On 27 June 2025, Denmark became one …